Chapter 110. Specific Immunotherapy in Allergic Rhinitis and Asthma

  1. William W. Busse MD1 and
  2. Stephen T. Holgate BSc, MD, FRCP2
  1. Pascal Demoly,
  2. Francois B. Michel and
  3. Jean Bousquet

Published Online: 16 APR 2008

DOI: 10.1002/9780470694923.ch40

Asthma and Rhinitis, Second Edition

Asthma and Rhinitis, Second Edition

How to Cite

Demoly, P., Michel, F. B. and Bousquet, J. (2000) Specific Immunotherapy in Allergic Rhinitis and Asthma, in Asthma and Rhinitis, Second Edition (eds W. W. Busse and S. T. Holgate), Blackwell Science Ltd, Oxford, UK. doi: 10.1002/9780470694923.ch40

Editor Information

  1. 1

    Professor of Medicine Head, Clinical Immunology, University of Wisconsin-Madison Medical School, Department of Medicine, Madison Wisconsin, USA

  2. 2

    Clinical Professor of Immuno-Pharmacology, Medical Specialties, Southampton General Hospital, Youthampton, UK

Publication History

  1. Published Online: 16 APR 2008
  2. Published Print: 1 JAN 2000

ISBN Information

Print ISBN: 9780632041756

Online ISBN: 9780470694923

SEARCH

Keywords:

  • specific immunotherapy;
  • allergic rhinitis;
  • asthma;
  • adhesion molecules;
  • lymphocyte subclass

Summary

This chapter contains section titled:

  • Introduction

  • Mechanisms

  • General Considerations

  • Allergenic Preparations

  • Efficacy and Safety of Subcutaneous Specific Immunotherapy

  • Long-Term Efficacy of Specific Immunotherapy

  • Local Immunotherapy

  • Indications

  • Monitoring

  • Acknowledgements

  • References